Use of Clarithromycin in Mustard-Induced Bronchiolitis
NCT00381147 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2009-01-07
Summary
We looked for the effectiveness of low-dose long-term prescription of clarithromycin in mustard-induced chronic pulmonary lesions, especially bronchiolitis obliterans
Conditions
- Bronchiolitis Obliterans
- Acute Obliterating Bronchiolitis
Interventions
- DRUG
-
Clarithromycin
Sponsors & Collaborators
-
Baqiyatallah Medical Sciences University
lead OTHER
Principal Investigators
-
Mostafa Ghanei, Professor · Research Center of Chemical Injuries, Baqyatallah Medical Sciences University, Tehran, Iran
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Iran
Study Locations
More Related Trials
-
Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis
NCT01255592 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis
NCT06958861 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Disease
NCT00371527 ·Status: COMPLETED ·Phase: NA
-
A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease
NCT01033487 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT01437540 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose Escalation Study of Bradanicline in Refractory Chronic Cough
NCT03622216 ·Status: COMPLETED ·Phase: PHASE2
-
Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease
NCT00376714 ·Status: COMPLETED ·Phase: PHASE2
-
Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial
NCT03846570 ·Status: TERMINATED ·Phase: PHASE3
-
The Effects of Inhaled Aclidinium Bromide/Formoterol Fumarate on Inspiratory Pleural Pressures in Smokers
NCT03104634 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)
NCT00891462 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination
NCT01462942 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD
NCT00421122 ·Status: COMPLETED ·Phase: PHASE3
-
Short-course Antibiotic Treatment in AECOPD: a Meta-analysis of Double-blind Studies
NCT05380375 ·Status: UNKNOWN
-
Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
NCT00430300 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT00706914 ·Status: TERMINATED ·Phase: PHASE2
-
A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation
NCT01712516 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Triple Therapy in COPD
NCT03724877 ·Status: COMPLETED
-
Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)
NCT00358436 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD Patients
NCT03022097 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease
NCT00495586 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Long-term Safety of QVA149
NCT01120717 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease. Ratio-Study. (BY217/M2-112)
NCT00430729 ·Status: COMPLETED ·Phase: PHASE3
-
Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis
NCT00524095 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Inhaled Bronchodilator in Non-CF Bronchiectasis With Airflow Limitation
NCT04509661 ·Status: UNKNOWN ·Phase: PHASE4
-
Lung Bioavailability and Total Systemic Exposure to Beclomethasone17MonoPropionate and Formoterol Across Two Strengths of NEXThaler Inhalation Powder
NCT01738087 ·Status: COMPLETED ·Phase: PHASE2